Microbial Keratitis in Cairo University Hospitals
Launched by KASR EL AINI HOSPITAL · May 20, 2022
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients presenting at the casualty who are clinically diagnosed as infectious keratitis , of all age groups and including both genders.
- Exclusion Criteria:
- • Patients presenting with clinical picture suggestive of
- • Viral keratitis solely without superimposed secondary infection.
- • Non infectious keratitis as peripheral ulcerative keratitis ( e.g. Mooren's ulcer, marginal keratitis, autoimmune keratitis )
About Kasr El Aini Hospital
Kasr El Aini Hospital, a prestigious medical institution affiliated with Cairo University, is dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence, the hospital serves as a leading sponsor of clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. The institution focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and contribute to the global medical community. By fostering collaboration and adhering to the highest ethical standards, Kasr El Aini Hospital plays a pivotal role in the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Yehia Mostafa, MD
Study Chair
Kasr Al Aini Hospital
Mohamed El Agha, MD
Study Director
Kasr Al Aini Hospital
Ihab Othman, MD
Study Director
Kasr Al Aini Hospital
Moushira Hosny, MD
Study Director
Kasr Al Aini Hospital
Nevien Lotfy, MSc
Principal Investigator
Kasr Al Aini Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials